.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Head & Heal concentrated 80.87% of May 2026 sales in Tincture & Sublingual, where category sales fell 13.04% year over year but rose 12.05% month over month, while Concentrates climbed to 18.66% mix with a 33.62% month-over-month increase despite no year-over-year baseline. Minor lines swung sharply: Topical shrank 70.08% year over year and 33.10% month over month to 0.30% share, whereas Edible, though just 0.17% share, jumped 217.15% month over month and 41.41% year over year, with brand-wide average price down 10.88% year over year and overall sales up 6.25% year over year. The pattern implies a reliance on Tincture & Sublingual for scale alongside opportunistic momentum in Concentrates, using price moderation to drive unit velocity while trimming underperforming Topical exposure.
Holding rank 2 in Tincture & Sublingual in New York alongside a 12.05% month-over-month rebound in that category positions Head & Heal to defend core shelf space even as its 13.04% year-over-year decline signals maturity risk. The 33.62% month-over-month rise in Concentrates and a 217.15% month-over-month spike in Edible indicate elasticity to promotional or distribution moves at lower price points, consistent with a 10.88% brand-wide price decline; taken together, the mix shift suggests a hedge strategy that stabilizes rank in the lead category while testing adjacent formats for incremental growth.
Competitive Landscape
Head & Heal sits at rank #2 in NY Tincture & Sublingual in May 2026, unchanged from #2 year over year, with stability reinforced by holding #2 across the past three months while previously peaking at #1 in December 2024; meanwhile, Ayrloom remains #1 year over year and currently, pairing that consistency with a 22.6% YoY sales increase, and Veterans Choice Creations (VCC) improved from #4 to #3 alongside a 14.0% YoY sales gain, whereas Mfny (Marijuana Farms New York) slipped from #3 to #4 with a 34.6% YoY sales decline; this configuration implies Head & Heal’s flat rank trajectory at #2 reflects durable share retention but also a narrowing path back to #1 as competitors either accelerate upward or contract sharply.
Notable Products
CBD Organic Full Spectrum Tincture (1200mg CBD, 30ml) posted the steepest decline in May 2026 at -48.6%, sliding to rank 8 while CBD Oil Cat Formulation (300mg CBD, 30ml) fell -33.2% at the same rank 8 slot, implying legacy CBD-only pet and wellness SKUs are losing pull. In contrast, Hybrid RSO Dablicator (1g) jumped +33.6% to rank 3 and CBD/THC 2:1 Relief Tincture (600mg CBD, 300mg THC, 30ml) rose +26.5% at rank 4, while Max Strength THC Tincture (1000mg THC, 30ml, 1oz) in rank 1 grew +5.2% with $122,747, indicating demand is concentrating in high-THC and multi-cannabinoid formulations. Five of the top eight are Tincture & Sublingual SKUs and two of the top four gained over +25%, so the mix tilts toward functional, higher-THC or blended formats that can anchor pricing power and shape future pipeline priorities.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
